Abstract | OBJECTIVE: METHODS: RESULTS: Intracellular rhodamine fluorescence intensity of the resistant cells was 31.19% of that in the parental cells (P < 0.01). No expression of P-gp was demonstrated, and that of MRP was very weak in the TPT-resistant cells (relative expression value = 0.057). BCRP was overexpressed in the TPT-resistant cells (relative expression = 0.66), but not in the parental cells. Transfer of ASODN into resistant cells resulted in a 59.42% reduction of BCRP gene expression (P < 0.05) and an obviously increased intracellular rhodamine fluorescence intensity from 5.42 to 16.63 (P < 0.05). CONCLUSION: The overexpression of BCRP which mediated drug efflux may play an important role in the induction of TPT-resistance in ovarian cancer.
|
Authors | Ping Jia, Shao-Bo Wu, Fang Li, Qian Xu, Ming-Fu Wu, Guo-Ning Liao, Yun-Ping Lu, Ding Ma |
Journal | Zhonghua zhong liu za zhi [Chinese journal of oncology]
(Zhonghua Zhong Liu Za Zhi)
Vol. 26
Issue 3
Pg. 139-42
(Mar 2004)
ISSN: 0253-3766 [Print] China |
PMID | 15196431
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ABCG2 protein, human
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- ATP Binding Cassette Transporter, Subfamily G, Member 2
- ATP-Binding Cassette Transporters
- Antineoplastic Agents
- Neoplasm Proteins
- RNA, Messenger
- Topotecan
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(genetics)
- ATP Binding Cassette Transporter, Subfamily G, Member 2
- ATP-Binding Cassette Transporters
(genetics)
- Antineoplastic Agents
(pharmacology)
- Cell Line, Tumor
- Drug Resistance, Neoplasm
- Female
- Humans
- Neoplasm Proteins
(genetics)
- Ovarian Neoplasms
(drug therapy, pathology)
- RNA, Messenger
(analysis)
- Topotecan
(pharmacology)
|